Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

NASDAQ:AIRS - US0094961002 - Common Stock

6.45 USD
-0.21 (-3.15%)
Last: 8/29/2025, 8:05:58 PM
6.45 USD
0 (0%)
After Hours: 8/29/2025, 8:05:58 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIRS. AIRS was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AIRS have multiple concerns. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AIRS had negative earnings in the past year.
In the past year AIRS had a positive cash flow from operations.
In multiple years AIRS reported negative net income over the last 5 years.
In the past 5 years AIRS always reported a positive cash flow from operatings.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

With a Return On Assets value of -7.32%, AIRS is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -15.92%, AIRS is doing worse than 63.73% of the companies in the same industry.
Industry RankSector Rank
ROA -7.32%
ROE -15.92%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With an excellent Gross Margin value of 63.26%, AIRS belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIRS has more shares outstanding than it did 1 year ago.
AIRS has more shares outstanding than it did 5 years ago.
AIRS has a worse debt/assets ratio than last year.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

AIRS has an Altman-Z score of 2.67. This is not the best score and indicates that AIRS is in the grey zone with still only limited risk for bankruptcy at the moment.
AIRS has a Altman-Z score (2.67) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.58 indicates that AIRS is somewhat dependend on debt financing.
The Debt to Equity ratio of AIRS (0.58) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 2.67
ROIC/WACCN/A
WACC8.64%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.64 indicates that AIRS may have some problems paying its short term obligations.
AIRS has a worse Current ratio (0.64) than 88.24% of its industry peers.
AIRS has a Quick Ratio of 0.64. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
AIRS's Quick ratio of 0.64 is on the low side compared to the rest of the industry. AIRS is outperformed by 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

AIRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -171.43%.
The Revenue for AIRS has decreased by -14.46% in the past year. This is quite bad
AIRS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.35% yearly.
EPS 1Y (TTM)-171.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-13.71%

3.2 Future

The Earnings Per Share is expected to grow by 35.70% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.40% on average over the next years.
EPS Next Y68.26%
EPS Next 2Y34.01%
EPS Next 3Y35.7%
EPS Next 5YN/A
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y3.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIRS is valued a bit more expensive than 62.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 108.83
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

AIRS's earnings are expected to grow with 35.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.01%
EPS Next 3Y35.7%

0

5. Dividend

5.1 Amount

AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (8/29/2025, 8:05:58 PM)

After market: 6.45 0 (0%)

6.45

-0.21 (-3.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners22.09%
Inst Owner Change12.12%
Ins Owners26.22%
Ins Owner Change4.04%
Market Cap402.74M
Analysts76
Price Target6.12 (-5.12%)
Short Float %32.49%
Short Ratio6.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)157.21%
Min EPS beat(2)67.32%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)4
Avg EPS beat(12)-90.01%
EPS beat(16)5
Avg EPS beat(16)-82.21%
Revenue beat(2)0
Avg Revenue beat(2)-3.35%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-4.55%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-4.25%
Revenue beat(12)2
Avg Revenue beat(12)-3.82%
Revenue beat(16)5
Avg Revenue beat(16)-1.75%
PT rev (1m)26.32%
PT rev (3m)80%
EPS NQ rev (1m)39.99%
EPS NQ rev (3m)-19.98%
EPS NY rev (1m)63.16%
EPS NY rev (3m)72.14%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-17.83%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.44
P/FCF N/A
P/OCF 38.74
P/B 4.42
P/tB N/A
EV/EBITDA 108.83
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.17
OCFY2.58%
SpS2.64
BVpS1.46
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.32%
ROE -15.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.26%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 12.8
Cap/Depr 83.5%
Cap/Sales 6.42%
Interest Coverage N/A
Cash Conversion 250.12%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z 2.67
F-Score3
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-171.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y68.26%
EPS Next 2Y34.01%
EPS Next 3Y35.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-13.71%
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y3.4%
EBIT growth 1Y-201.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.71%
EBIT Next 3Y22.54%
EBIT Next 5YN/A
FCF growth 1Y-101.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.12%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%